I don't think people are too happy with the message from the CEO. It sounds like they intend to use cells only manufactured at the new facility, which will not be completed until near year-end, which means the trials cannot start until late this year or early next year. I think that is what is causing the recent selloff. It will be a longer wait than many had hoped.